TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
NextCell Pharma AB
Closing information (x1000 DKK)
Closing information | 2023/08 | 2022/08 | 2021/08 |
Turnover |
6,364
|
3,892
|
2,863 |
Financial expenses |
2
|
10
|
6 |
Earnings before taxes |
-25,053
|
-24,060
|
0 |
EBITDA |
-25,520
|
-24,069
|
320 |
Total assets |
55,897
|
86,796
|
113,905 |
Current assets |
42,333
|
74,333
|
107,211 |
Current liabilities |
6,343
|
4,827
|
2,896 |
Equity capital |
47,653
|
80,449
|
109,856 |
- share capital |
4,435
|
4,907
|
5,159 |
Employees (average) |
17
|
15
|
13 |
Financial ratios
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Solvency |
85.3%
|
92.7%
|
96.4% |
Turnover per employee |
374
|
259
|
220 |
Profit as a percentage of turnover |
-393.7%
|
-618.2%
|
0% |
Return on assets (ROA) |
-44.8%
|
-27.7%
|
0.0% |
Current ratio |
667.4%
|
1539.9%
|
3702.0% |
Return on equity (ROE) |
-52.6%
|
-29.9%
|
0% |
Change turnover |
2,847
|
1,168
|
254 |
Change turnover % |
81%
|
43%
|
10% |
Chg. No. of employees |
2
![]() |
2
|
3 |
Chg. No. of employees % |
13%
|
15%
|
30% |
Total value of public sale
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.